Why Are Alternative Options for Treating Chronic Bone and Joint Infections Needed?
APR 22, 2019 | CONTAGION® EDITORIAL STAFF
Segment Description: Tristan Ferry, MD, PhD, co-head of the Infectious Diseases Unit at Lyon University Hospital in France, discusses why there is a need to develop alternatives to treat chronic bone and joint infections.
Interview transcript (modified slightly for readability):
Contagion®: Your talk covered alternative options to managing chronic bone and joint infections. Why are the alternative options needed?
Dr. Ferry: Patients with chronic bone and joint infections are very difficult to treat because they are infected with persisters bacteria and it's very difficult to eradicate. Most patients require surgery that could be associated with a loss of function such as explantation. It's very important to imagine the different options to limit the consequence of invasive surgery with some antibiotics or anti-persisters that could act on the bacteria to cure the patient.
The symposium, "Alternative options to rescue patients: novel anti-persister antibiotics, local antibiotic delivery, phage therapy," was presented Saturday, April 13, at ECCMID 2019.
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Big advances in treatment can't make up for an inability to stop new infections, which number 5,000 per day worldwide.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512